baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Abeona Therapeutics Inc/ US00289Y2063 /

2024-05-31 6:47:23 PM	Chg. +0.0550	Volume	Bid6:48:17 PM	Ask6:48:17 PM	High	Low
4.2650USD	+1.31%	164,600 Turnover: 665,415.5452	4.2600Bid Size: 100	4.2700Ask Size: 300	4.3900	4.2200

GlobeNewswire 05-28 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeut...

GlobeNewswire 05-28 Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference

GlobeNewswire 05-21 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeut...

GlobeNewswire 05-15 Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress

GlobeNewswire 05-12 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeut...

GlobeNewswire 05-07 Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 05-06 Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider

GlobeNewswire 05-03 Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-F...

GlobeNewswire 05-01 SHAREHOLDER ALERT: Abeona Therapeutics Investigated by Block & Leviton For Potential Securities Law ...

GlobeNewswire 04-25 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeut...

GlobeNewswire 04-23 SHAREHOLDER ALERT: Abeona Therapeutics Investigated by Block & Leviton For Potential Securities Law ...

GlobeNewswire 04-22 Abeona Therapeutics Provides Regulatory Update on Pz-cel

GlobeNewswire 04-01 Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 03-18 Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspect...

GlobeNewswire 03-05 Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 02-29 PRISM MarketView Highlights Work of Emerging Companies on Rare Disease Day

GlobeNewswire 02-07 Artios Pharma Strengthens Financial Leadership with Appointment of Christine Silverstein as Chief Fi...

GlobeNewswire 02-01 Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 02-01 Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)

GlobeNewswire 01-08 Abeona Therapeutics Announces $50 Million Credit Facility

GlobeNewswire 2023-12-15 Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 2023-11-27 Abeona Therapeutics Announces FDA Accepts and Grants Priority Review for Pz-cel Biologics License Ap...

GlobeNewswire 2023-11-13 Abeona Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Developments

GlobeNewswire 2023-11-01 Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 2023-09-26 Abeona Therapeutics Submits Biologics License Application to U.S. FDA Seeking Priority Review and Ap...

Abeona Therapeutics Inc/ US00289Y2063 /

If you wish to receive reply to your feedback, please provide your email address.